Director/PDMR Shareholding

Summary by AI BETAClose X

CT Healthcare Trust plc announced that Sarah MacAulay, a person discharging managerial responsibilities, and her closely associated person purchased a total of 67,000 ordinary shares on 17 August 2026 at a price of £1.418 per share on the London Stock Exchange. This transaction represents an initial notification and involves the acquisition of ordinary shares with the identification code GB00BZCNLL95.

Disclaimer*

CT Healthcare Trust PLC
18 August 2026
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Sarah MacAulay and PCA

2

 

Reason for the notification

 

a)

 

Position/status

 

 

i) Sarah MacAulay - PDMR

ii) PCA to Sarah MacAulay

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CT Healthcare Trust plc

b)

 

LEI

 

 

LEI: 213800HQ3J3H9YF2UI82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p

 

 

 

GB00BZCNLL95

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

i) £1.418

ii) £1.418

 

30,000 shares

37,000 shares

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

17 August 2026

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings